Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
Patrick N. A. Harris(University of Technology Sydney), David L. Paterson(The University of Queensland), John F. McNamara(Prince Charles Hospital), Riccardo Utili(University of Campania "Luigi Vanvitelli"), Guy Thwaites(University of Oxford), Keith S. Kaye(University of Michigan), Joshua S. Davis(John Hunter Hospital), Allen Cheng(Menzies School of Health Research), Leonard Leibovici(Rabin Medical Center), David Chien Lye(National University of Singapore), Benjamin A. Rogers(Monash University), Vance G. Fowler(Clinical Research Institute), Louis Bernard(Université de Tours), Martin Llewelyn(Brighton and Sussex Medical School), Jesús Rodríguez‐Baño(Hospital Universitario Virgen Macarena), Jeffrey Lipman(Royal Brisbane and Women's Hospital), Mical Paul(Rabin Medical Center), Steven Y. C. Tong, Visanu Thamlikitkul, Harald Seifert(University of Cologne), L. Silvia Muñoz-Price(Medical College of Wisconsin), Anton Y. Peleg(Australian Regenerative Medicine Institute), John Turnidge(The University of Adelaide), S. A. R. Webb(Royal Perth Hospital), Yohei Doi(Fujita Health University)
Cited by 83
Related Papers
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
|Clinical Microbiology Reviews|2015|5.1k
Antimicrobial Resistance in ESKAPE Pathogens
|Clinical Microbiology Reviews|2020|2k
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research
|Nature Reviews Microbiology|2019|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care
|New England Journal of Medicine|2012|1.7k